Neuraptive Therapeutics, Inc.
Biotechnology company · Philadelphia, Pennsylvania, United States
Neuraptive Therapeutics, Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $19 million sold in a notice filed in 2022.
Neuraptive Therapeutics at a glance
What does Neuraptive Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $19.5 million sold (2022).
Frequently asked questions about Neuraptive Therapeutics
Where is Neuraptive Therapeutics headquartered?
Neuraptive Therapeutics, Inc. is headquartered in Philadelphia, Pennsylvania, United States.
What does Neuraptive Therapeutics do?
Neuraptive Therapeutics, Inc. is a biotechnology company.
When was Neuraptive Therapeutics founded?
The earliest incorporation on record for Neuraptive Therapeutics, Inc. is in 2017, according to public company registers.
Similar companies
- Spark Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Cabaletta Bio, Inc.Philadelphia, Pennsylvania, United States
- Passage BIO, Inc.Philadelphia, Pennsylvania, United States
- ZSX Medical, LLCPhiladelphia, Pennsylvania, United States
- Enterin, Inc.Philadelphia, Pennsylvania, United States
- Century Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- PolyCore Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Five Eleven Pharma Inc.Philadelphia, Pennsylvania, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences